Biocidal Products Risk Assessment Guideline Published: New Regulatory and Implementation Guide
Date: 29 January 2026
The newly published guideline clarifies the expected risk assessment dataset and evaluation logic for biocidal products. It aligns with the EU Biocidal Products Regulation (BPR, Regulation (EU) No 528/2012) and provides an application framework consistent with Turkey's Biocidal Products Regulation, KKDIK (Turkish REACH) and REACH.
---
Legal references & regulatory framework
- EU BPR (Regulation (EU) No 528/2012)
- ECHA Guidance on the BPR (Risk Assessment)
- Turkey Biocidal Products Regulation (Ministry of Health)
- KKDIK (Turkish REACH) and REACH data requirements
---
EU + Turkey alignment (REACH + KKDIK)
Risk assessment covers substance identity, exposure scenarios, toxicological/ecotoxicological endpoints and classification approach. Much of this overlaps with REACH/KKDIK datasets. The guideline explains how to use REACH/KKDIK data in biocidal dossiers and how to close data gaps.
---
Industry impact
- Data gap analysis for active substances and product dossiers
- Testing strategy and laboratory planning
- UVCB / same substance and similarity justification
- Authorization timeline, labeling and safety documentation
---
How Pier Compliance helps
- Risk assessment strategy and data gap mapping
- Integrating KKDIK/REACH data into biocidal dossiers
- Test plan, lab coordination, dossier-ready reporting
- Authority communication and authorization process management
---
CTA
Contact us to apply the new biocidal products risk assessment guideline and accelerate authorization → /contact